European-wide study confirms benefits of D-penicillamine and trientine for Wilson disease
Links shared publicly online about this topic.
- 399total visits
European-wide study confirms benefits of D-penicillamine and trientine for Wilson disease
Results from the first ever European-wide retrospective analysis presented today at the International Liver CongressTM have shown both D-penicillamine and trientine continue to be effective treatments, providing positive survival rates in patients with Wilson disease free from a liver transplant.
View full resource at physorg.com
Tags: Liver, Wilson Disease, Organ Transplantation, Liver Transplant, Disease and Condition, Transplantation, disease
Most Recently Shared on March 31, 2011 at 1:32 pm By:
European-wide study confirms benefits of D-penicillamine and trientine for Wilson disease http://tw.physorg.com/220782475
Advertisement
